Literature DB >> 26919856

[Hospital financing in 2016. Relevant changes for rheumatology].

W Fiori1, H Bunzemeier2, H-J Lakomek3, K Buscham3, H Lehmann4, A-K Fuchs5, F Bessler6, N Roeder7.   

Abstract

Hospital financing 2016 will be influenced by the prospects of the approaching considerable changes. It is assumed that the following years will lead to a considerable reallocation of financial resources between hospitals. While not directly targeted by new regulations, reallocations always also affect specialties like rheumatology. Compared to the alterations in the legislative framework the financial effects of the yearly adaptation of the German diagnosis-related groups system are subordinate. Only by comprehensive consideration of current and expected changes a forward-looking and sustainable strategy can be developed. The following article presents the relevant changes and discusses the consequences for hospitals specialized in rheumatology.

Keywords:  Additional remuneration; Audits; Coding; Diagnosis-related groups; Rheumatology

Mesh:

Year:  2016        PMID: 26919856     DOI: 10.1007/s00393-016-0052-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  13 in total

1.  [Hospital financing in 2012 - Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

3.  [G-DRG system 2009: relevant changes for rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

4.  [The G-DRG system 2008. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; J L Hülsemann; N Roeder
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

5.  [Hospital financing for 2011: relevant changes in rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

6.  [The "outcome benchmarking in rheumatologic acute care" project of the Association of Rheumatologic Acute Care Clinics (VRA e.V.) in Germany].

Authors:  Norbert Roeder; Heinz-Jürgen Lakomek
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2011-06-16

7.  [Hospital financing in 2015. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

8.  [Hospital financing in 2013: relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

9.  [Hospital financing in 2014. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 10.  [Treat-to-target (T2T) from the perspective of inpatient rheumatology].

Authors:  H-J Lakomek; A Krause
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.